Varicose Vein Treatment Devices Market Expected to Achieve 8.6% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Varicose Vein Treatment Devices Market Size By 2025?
The market for varicose vein treatment devices has seen powerful growth over recent years, expanding from a valuation of $1.31 billion in 2024 to a projected $1.42 billion in 2025, which represents a compound annual growth rate (CAGR) of 8.2%. The significant growth during the historic period is linked to several factors such as the swelling aged population, heightened awareness about varicose veins, an upsurge in the demand for less invasive procedures, elevated healthcare spending, and a surge in diseases related to lifestyle.

How Big Is the Varicose Vein Treatment Devices Market Size Expected to Grow by 2029?
The market for varicose vein treatment devices is forecasted to experience robust growth in the coming years, with projections estimating it will reach a value of $1.97 billion by 2029, expanding at a compound annual growth rate (CAGR) of 8.6%. This growth during the predicted period can be accounted to factors such as growing public consciousness, increased disposable incomes, an amplified occurrence of varicose veins, the development of healthcare systems in emerging markets, and an ascending obese population. Future trends during this period appear to include a transition to outpatient treatments, the adoption of laser and radiofrequency technologies, technological progressions, an elevated acceptance of ambulatory care centers, and a rising need for home-based treatment apparatuses.

View the full report here:
https://www.thebusinessresearchcompany.com/report/varicose-vein-treatment-devices-global-market-report

Which Key Market Drivers Powering Varicose Vein Treatment Devices Market Expansion and Growth?
The increasing cases of obesity are anticipated to stimulate the expansion of the varicose veins treatment devices market in the near future. The medical condition of obesity is characterized by an excessive accumulation of body fat, potentiating serious health complications like diabetes, cardiovascular issues, and joint problems. The escalating obesity rates typically stem from a cocktail of unfavorable dietary habits, lack of physical activity, and environmental influences targeting unhealthy food consumption, while genetic factors, socio-economic status, and mental well-being also play a significant role in its increasing prevalence. Varicose vein therapy devices have proven beneficial to those suffering with obesity by lessening vein-related issues, boosting blood flow, alleviating discomfort and swelling due to elevated weight, and advocating for enhanced mobility and comprehensive vascular health. For example, in March 2023, the Switzerland-based World Heart Foundation, a global non-government healthcare organization focusing on cardiovascular health, stated that at present around 2.3 billion adults and children globally struggle with obesity or are overweight. Given the continual trend in obesity, this figure is predicted to escalate to 2.7 billion by 2025. Consequently, the rising occurrence of obesity is fueling growth in the varicose veins treatment devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20996&type=smp

Which Emerging Trends Are Transforming the Varicose Vein Treatment Devices Market in 2025?
Leading firms in the varicose veins treatment devices market are zeroing in on the creation of novel solutions such as minimally invasive technologies. These technologies are aimed at delivering precise treatment while reducing patient discomfort and hastening recovery time. The term distinguishes surgical methodologies that involve small incisions and sophisticated equipment, including endoscopes and robotic systems, which enable procedures to be performed more smoothly, with less trauma, quicker convalescence, and a decrease in complications likelihood in comparison to traditional open surgery. For example, in June 2023, Austria's medical technology corporation Biolitec AG, unveiled the Elves Radial 2ring Pro laser fiber and the Leonardo 1940 laser, designed for varicose vein treatments. The Elves Radial 2ring Pro laser fiber has an extra channel for a saline solution, facilitating vein expansion prior to laser treatment. In contrast, the Leonardo 1940 laser possesses a wavelength that enhances vein wall absorption thereby minimising bruising and recovery duration. Such innovations substantially amplify the effectiveness and cosmetic results of varicose vein treatments, presenting a more viable approach for eliminating large and twisted veins.

What Are the Emerging Segments in the Varicose Vein Treatment Devices Market?
The varicose vein treatment devices market covered in this report is segmented -

1) By Device Type: Ablation Devices, Venous Closure Products, Other Device Products
2) By Treatment Type: Sclerotherapy, Endovenous Ablation, Surgical Ligation And Stripping, Other Treatment Type
3) By Patient Type: Adults, Elderly
4) By End-User: Specialty Clinics, Hospitals, Ambulatory Surgical Services, Other End-Users

Subsegments:
1) By Ablation Devices: Radiofrequency Ablation (RFA) Devices, Laser Ablation Devices, Endovenous Laser Therapy (EVLT) Devices, Cryoablation Devices, Ultrasound-Guided Foam Sclerotherapy Devices
2) By Venous Closure Products: VenaSeal Closure System, ClariVein Closure System, Mechanical Endovenous Ablation Devices, Stenting Systems For Venous Closure
3) By Other Device Products: Sclerotherapy Kits, Varicose Vein Removal Lasers, Compression Therapy Devices, Surgical Instruments For Vein Stripping, Endovenous Laser Fibers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20996&type=smp

Who Are the Global Leaders in the Varicose Vein Treatment Devices Market?
Major companies operating in the varicose vein treatment devices market are Medtronic Plc, Boston Scientific Corporation, Teleflex Incorporated, Merit Medical Systems, Lumenis Be Ltd., AngioDynamics Inc., Candela Medical, Alma Lasers, Dornier Medtech, Fotona d.o.o., Sciton Inc., Won Tech Co. Ltd, Quanta System SpA, biolitec Holding GmbH & Co KG, Eufoton SRL, Myovatec Surgical Systems, Chemische Fabrik Kreussler & Co., Ad Rem Technology, VB Devices, Theraclion, InVera Medical

Which are the Top Profitable Regional Markets for the Varicose Vein Treatment Devices Industry?
North America was the largest region in the varicose vein treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the varicose vein treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20996

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.